US EditionAgenus and Zydus Lifesciences Enter $141MM Partnership that Includes Transfer of Facilities in Emeryville and Berkeley - The Registry
Summary by The Registry
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Agenus and Zydus Lifesciences Enter $141MM Partnership that Includes Transfer of Facilities in Emeryville and Berkeley - The Registry
(Editor’s Note: According to industry reports, the Berkeley facility is 25,000 square feet and located at 901 Heinz Ave., and the Emeryville asset spans 83,000 square feet and is positioned at 6455 Christie Ave.) LEXINGTON, Mass.– Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced it has signed definitive partnership agreements with Zydus Lifesciences […] The post Agenus and Zydus Lifesciences Enter $141MM Partn…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
